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The  acaricidal  efﬁcacy  of  a novel  oral  formulation  of afoxolaner  (NEXGARD®, Merial)  against
two European  tick  species  was  assessed  in  dogs  experimentally  infested  with  Ixodes  ricinus
and Dermacentor  reticulatus.  Three  studies,  each  characterized  by a negative  controlled
randomized  block  design,  were  conducted  with  a total of  52  beagle  or  mongrel  dogs  of  both
sexes.  Starting  2 days  before  treatment,  each  dog  was  infested  weekly  with  approximately
50  ticks.  The  number  of live ticks  was counted  at 48  h  post-treatment  (Day  2) as  well  as  48 h
following  each  infestation  on  Days  9, 16,  23,  and  30.  Afoxolaner,  administered  at  an  average
dose of 2.7  mg/kg  bodyweight  (range  2.5–2.9  mg/kg),  rapidly  eliminated  the  pre-existing
tick  infestations  with  over  99%  acaricidal  efﬁcacy  and  controlled  the  weekly  re-infestations
for  up  to 30  days  post  treatment  with over  96% efﬁcacy  on  both  tick  species.  Afoxolaner
provides  excellent  acaricidal  efﬁcacy  against  these  two  major  European  tick species  using
the oral  route  of  administration.
©  2014  The  Authors.  Published  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Ticks are endemic throughout Europe with more than
twelve different species, which have varying biology and
geographic distribution (Chomel, 2011). Ixodes ricinus and
Dermacentor reticulatus commonly infest dogs and are vec-
tors of various canine vector borne pathogens including
Borrelia burgdorferi and Anaplasma phagocytophilum,  both
transmitted by I. ricinus,  and Babesia canis transmitted by
D. reticulatus (Chomel, 2011; Dantas-Torres et al., 2012). I.
ricinus is found throughout Europe, except on the Mediter-
ranean border, and D. reticulatus is widely distributed with
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licenses/by-nc-nd/3.0/).areas of tick concentration dependent upon local environ-
mental conditions (Beugnet and Chalvet-Monfray, 2013).
The distribution of both tick species has been expand-
ing in Europe as a result of climate change (Beugnet and
Chalvet-Monfray, 2013; Daniel et al., 2003; Gray et al.,
2009; Smith et al., 2011). The period of tick activity
also is increasing in Europe. For example, in Hungary
the total duration of I. ricinus activity was shown to
be 2 months longer in 2002 compared to the duration
in 1950, and ticks were also found in winter, a ﬁnd-
ing not described in 1950 (Smith et al., 2011). Similar
ﬁndings are described for I. ricinus or D. reticulatus in
Belgium, Switzerland, Poland, Germany, Slovenia and Slo-
vakia (Bullova et al., 2009; Chomel, 2011; Reis et al., 2011;
Siroky et al., 2011). Although more common in colder
climates, I. ricinus can be found in the warmer climate
conditions of the Mediterranean region as demonstrated
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Table  1
Study design to evaluate the efﬁcacy of afoxolaner against Dermacentor reticulatus and Ixodes ricinus.
Tick species Study code Dog breed, age (months),
body weight (kg)
Number of dogs in
control/treated groups
Average dosage of afoxolaner
mg/kg (min–max)
A – unfed dogs Cross breed, >6, 11.0–18.4 8/8 2.71 (2.5–2.9)
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Ixodes  ricinus C – fed dogs Beagle, 11–13
y Dantas-Torres and Otranto (2013), who showed that
. ricinus is present in southern Italy where it remains
ctive throughout the year with spatiotemporal distri-
ution patterns that are distinct from central and north
uropean populations. The expansion of the geographic
nd temporal incidence of ticks throughout Europe and the
ncreased movement of people and their companion ani-
als between countries strengthen the need for effective
ick control measures for dogs year-round (Otranto et al.,
009a,b).
The present study describes the results of three exper-
mental studies that assessed the efﬁcacy of afoxolaner,
 new insecticide–acaricide administered orally in a soft
hewable formulation (Nexgard®, Merial), against I. ricinus
nd D. reticulatus in dogs. This new acaricide was  tested
or its curative property (i.e., its ability to kill ticks when
dministered to an infested dog), and for its prophylactic
roperties (i.e., its ability to prevent tick re-infestations for
0 days after treatment).
. Materials and methods
Fifty-two dogs were included in three laboratory stud-
es. Each study included 16–20 beagle or mongrel dogs of
oth sexes using a negative controlled randomized block
esign (Table 1). All dogs were healthy, >6 months of
ge, between 7.9 and 18.4 kg bodyweight at inclusion, and
o dogs had been infested by ticks nor treated with any
nsecticidal–acaricidal drug in a 3-month period before
nclusion.
The health condition of all dogs was monitored at
east once daily and additionally once per hour during the
rst four h post treatment. They were acclimated to the
tudy conditions for at least 7 days prior to treatment. All
ogs had free access to water and were fed a commer-
ial diet provided in an amount and manner that supplied
utrient and energy requirements to ensure their health
nd well-being. All animal procedures in this study were
eviewed and approved by the Merial Ethics Committee
USDA, 2008). The study design was in accordance with the
orld Association for the Advancement of Veterinary Para-
itology (WAAVP) guidelines for evaluating the efﬁcacy of
arasiticides for the treatment, prevention and control of
ea and tick infestation on dogs and cats (Marchiondo et al.,
013), and was conducted in accordance with Good Clinical
ractices as described in International Cooperation on Har-
onisation of Technical Requirements for Registration of
eterinary Medicinal Products (VICH) guideline GL9 (EMEA,
000).
In each of the 3 studies, two groups of equal size
ere randomly formed based on decreasing pre-treatment
ick counts (performed during acclimation, 48 h after8.1 10/10 2.76 (2.5–2.9)
.5 8/8 2.73 (2.5–2.95)
infestation). Dogs were either untreated or treated once
orally with the appropriate combination of soft chews con-
taining afoxolaner (day of treatment was  Day 0). Four sizes
of chews were available: 0.5 g, 1.25 g, 3 g and 6 g, contain-
ing respectively 11.3 mg,  28.3 mg,  68 mg  and 136 mg  of
afoxolaner. As the soft chews cannot be cut, the dosing
was administered by giving one or more of the chews to
be as close as possible to the minimum effective dose of
2.5 mg/kg, resulting in an average dose of 2.7 mg/kg of afox-
olaner per each treated group (Table 1). Dogs were fasted
overnight prior to treatment and fed approximately four h
after treatment in Study A but were fed in the hour before
treatment in Studies B and C.
On Days −2, 7, 14, 21 and 28, all dogs were infested with
50 unfed adult ticks (with approximately equal sex ratio for
D. reticulatus in Studies A and B, and 50 females of I. rici-
nus, with 10 additional males to stimulate attachment, in
Study C). Ticks were from laboratory-maintained popula-
tions that had been established from ticks collected in ﬁeld
locations in Europe. Live ticks were counted and removed
48 h after treatment or infestations on Days 2, 9, 16, 23,
and 30. These counts consisted of the methodical exami-
nation of all body areas using ﬁnger tips and/or a coarse
tooth comb to sort through the hair and locate all ticks on
the animal, as described by Marchiondo et al. (2013). All
personnel conducting tick counts and health observations
were blinded to treatment groups.
For each tick count, including male and female ticks,
the total count of live adult ticks was  transformed to the
natural logarithm of (count + 1) to calculate the geomet-
ric mean for each treatment group. The percent reduction
of the tick counts from treated dogs compared to those
from untreated dogs (= percentage efﬁcacy) was calculated
using the formula [(C − T)/C] × 100, where C is the geomet-
ric mean for the control group and T is the geometric mean
for the treated group at the same time point. The tick counts
of the treated and untreated groups were also compared
using Friedman’s test. All testing was two-sided at the sig-
niﬁcance level p = 0.05.
For each study, the therapeutic efﬁcacy of afoxolaner
against Day −2 infestation and the efﬁcacy of afoxolaner
in the prevention of weekly tick re-infestations starting on
Day 7 after treatment were assessed.
3. Results
In the control groups, the geometric mean of live ticks
counted at each time point was  between 19.9 and 32.3
for infestations with D. reticulatus and between 23.4 and
34.2 for I. ricinus (Table 2). To allow the comparison
between control and treated groups, the minimum reten-
tion rate of ticks should be at least 20% (i.e., 10 ticks for an
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Table 2
Geometric mean number of live ticks in the control groupa (min–max tick count) 48 h after infestation.
Tick species Study code Study day
2 9 16 23 30
Dermacentor reticulatus
A 30.6 (14–44) 21.5 (13–33) 25.7 (14–40) 29.4 (15–43) 19.9 (9–32)
B  32.3 (17–48) 25.2 (8–47) 24.6 (13–39) 22.1 (13–48) 20.5 (18–43)
Ixodes ricinus C 34.2 (25–42) 27.0 (20–37) 23.6 (15–28) 23.4 (19–28) 23.8 (19–32)
a 50 unfed ticks of equal sex ratio were used for infestation with D. reticulatus. 50 unfed female ticks with approximately 10 males were used for infestation
with  I. ricinus.
Table 3
Percent efﬁcacy of afoxolaner against Dermacentor reticulatus and Ixodes ricinus and 48 h after treatment/infestation (geometric means count in the treated
group).a
Tick species Study code Percent efﬁcacy
Study day
2b 9c 16c 23c 30c
Dermacentor reticulatus
A – unfed dogs 100 (0.0) 98.5 (0.3) 97.9 (0.5) 98.2 (0.5) 97.6 (0.5)
B  – fed dogs 100 (0.0) 99.7 (0.1) 99.2 (0.2) 98.0 (0.4) 96.4 (0.7)
Ixodes ricinus C – fed dogs 100 (0.0) 100. (0.0) 100 (0.0) 100 (0.0) 99.6 (0.1)
a A signiﬁcant difference (p < 0.002) was demonstrated between the geometric mean counts of the control and treated group in each study at each time
point.
b Therapeutic efﬁcacy of afoxolaner against Day −2 infestation.
c Prophylactic efﬁcacy against weekly tick re-infestations.
infestation with 50) in order to make a valid assessment
of tick efﬁcacy (Marchiondo et al., 2013). The control dogs
were adequately infested in the 3 studies.
In the treated groups, the tick reduction was signiﬁcant
(p < 0.002) compared to the control groups for each time
point of each study (Table 3). Afoxolaner treatment pro-
vided a complete elimination of all ticks when infestation
existed prior to treatment (therapeutic efﬁcacy) and pro-
vided over 96.4% acaricidal efﬁcacy against D. reticulatus
and over 99.6% against I. ricinus up to Day 30 (Table 3)
when infestations occurred after treatment (prophylac-
tic efﬁcacy). No adverse effects related to treatment were
observed.
4. Discussion
A single oral treatment with the chewable formulation
of afoxolaner achieved 100% therapeutic efﬁcacy for treat-
ing pre-existing infestations by I. ricinus and D. reticulatus.
It also controlled re-infestations of ticks within 48 h for 4
weeks after treatment as demonstrated by the prophylac-
tic efﬁcacy, which was over 96.4% for the 2 studies against
D. reticulatus and over 99.6% for the I. ricinus study. No dif-
ference was observed in efﬁcacy against D. reticulatus ticks
between fasted (Study A) and fed (Study B) dogs. Treated
dogs in all three studies accepted the afoxolaner chews
without adverse reactions, based on hourly post-treatment
observations and daily observations.
The acaricidal efﬁcacy of afoxolaner against I. ricinus
and D. reticulatus observed in these studies was similar
to what is usually observed with topical products. For
example, against I. ricinus,  two spot-on solutions, one with
pyriprole and one with permethrin/imidacloprid provided
a curative efﬁcacy of 100% and 67.0%, respectively on Day
2, and greater than 98.7% prophylactic efﬁcacy up to 30days when assessed 48 h after tick infestations (Epe et al.,
2003; Schuele et al., 2008). In a study comparing three
topical treatments against D. reticulatus (Tielemans et al.,
2010), the efﬁcacies were 100%, 76% and 70% on Day 30
for ﬁpronil/(S)-methoprene, permethrin/imidacloprid and
metaﬂumizone/amitraz, respectively. The oral formulation
of afoxolaner is the ﬁrst one to provide an efﬁcacy against
tick for a month, as it is described for topical products.
Nevertheless, no direct comparison is available.
The systemic distribution of the tested product offer
advantages compared to the topical formulations. One ben-
eﬁt is the lower possibility of exposure of the owner during
the time necessary for a topical product to be absorbed
through the skin of a treated dog. Another signiﬁcant
advantage of an orally administered, systemically active
product is that rainy conditions, shampooing, or other
concurrent topical treatments will not interfere with the
efﬁcacy (Beugnet and Franc, 2012).
In conclusion, the chewable formulation containing the
new insecticide–acaricide afoxolaner is a convenient and
efﬁcacious ectoparasiticide treatment for dogs that treats
and prevents tick infestations for up to 1 month.
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